BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Healthtrust
Deloitte
McKinsey
Teva
AstraZeneca
Cipla
Boehringer Ingelheim
Merck
Federal Trade Commission

Generated: January 22, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,424,295

« Back to Dashboard

Summary for Patent: 5,424,295
Title: 9-.beta.-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine
Abstract:The compound 9-B-D-arabinofuranosyl-2-amino-6-methoxy-9H-purine along with its 5'-acetyl and 5'-(4-methoxy-4-oxobutyryl derivatives are disclosed as inhibitors of Varicella Zoster virus (VZV).
Inventor(s): Krenitsky; Thomas A. (Chapel Hill, NC), Porter; David J. T. (Raleigh, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:08/110,487
Patent Claims: 1. 9-.beta.-D-Arabinofuranosyl-2-amino-6-methoxy-9H-purine.

2. 2-Amino-6-methoxy-9-(5-O-acetyl-.beta.-D-arabinofuranosyl)-9H-purine.

3. A pharmaceutically acceptable salt of 2-amino-6-methoxy-9-(5-O-acetyl-.beta.-D -arabinofuranosyl)-9H-purine.

4. A pharmaceutical composition comprising 2-amino-6-methoxy-9-(5-O-acetyl-.beta.-D -arabinofuranosyl)-9H-purine or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier therefor.

5. 2-Amino-6-metho xy-9-(5-O-(4-methoxy-4-oxobutyryl)-.beta.-D-arabinofuranosyl)-9H-purine or a pharmaceutically acceptable salt thereof.

6. A pharmaceutically acceptable salt of 9-.beta.-D -Arabinofuranosyl-2-amino-6-methoxy-9H-purine.

7. A pharmaceutical composition comprising 9-.beta.-D -Arabinofuranosyl-2-amino-6-methoxy-9H-purine and a pharmaceutically acceptable carrier therefor.

8. A pharmaceutical composition comprising a pharmaceutically acceptable salt of 9-.beta.-D-Arabinofuranosyl-2-amino-6-methoxy-9H-purine and a pharmaceutically acceptable carrier therefor.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
Accenture
Deloitte
Teva
Express Scripts
US Army
Cerilliant
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot